Aim: Systemic sclerosis (SSc) is a rare, chronic autoimmune disease associated with a substantial economic burden. This study aimed to assess the costs associated with SSc and to identify major cost drivers.
Methods: A systematic search was conducted in MEDLINE and Embase to identify relevant studies.